Authors: Thanakornyothin, N Susin, M Benoff, S Wilkes, BM

Citation: N. Thanakornyothin et al., Increased renin immunostaining in preglomerular arterioles after myocardial infarction in the rat, J LA CL MED, 137(1), 2001, pp. 21-27

Authors: Rosenberg, ES Altfeld, M Poon, SH Phillips, MN Wilkes, BM Eldridge, RL Robbins, GK D'Aquila, RT Goulder, PJR Walker, BD

Citation: Es. Rosenberg et al., Immune control of HIV-1 after early treatment of acute infection, NATURE, 407(6803), 2000, pp. 523-526

Authors: Chertow, GM Dillon, M Burke, SK Steg, M Bleyer, AJ Garrett, BN Domoto, DT Wilkes, BM Wombolt, DG Slatopolsky, E

Citation: Gm. Chertow et al., A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium - Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients, CLIN NEPHR, 51(1), 1999, pp. 18-26

Authors: Wilson, CC Brown, RC Korber, BT Wilkes, BM Ruhl, DJ Sakamoto, D Kunstman, K Luzuriaga, K Hanson, IC Widmayer, SM Wiznia, A Clapp, S Ammann, AJ Koup, RA Wolinsky, SM Walker, BD

Citation: Cc. Wilson et al., Frequent detection of escape from cytotoxic T-lymphocyte recognition in perinatal human immunodeficiency virus (HIV) type 1 transmission: the Ariel Project for the Prevention of Transmission of HIV from Mother to Infant, J VIROLOGY, 73(5), 1999, pp. 3975-3985

Authors: Wilkes, BM Reiner, D Kern, M Burke, S

Citation: Bm. Wilkes et al., Simultaneous lowering of serum phosphate and LDL-cholesterol by sevelamer hydrochloride (RenaGel) in dialysis patients, CLIN NEPHR, 50(6), 1998, pp. 381-386